Back to Journals » OncoTargets and Therapy » Volume 11

Review

The return of gemtuzumab ozogamicin: a humanized anti-CD33 monoclonal antibody–drug conjugate for the treatment of newly diagnosed acute myeloid leukemia

       
Total article views   HTML views PDF downloads Totals
14,548 Dovepress* 11,458+ 1,356 12,814
PubMed Central* 3,090 901 3,991
Totals 14,548 2,257 16,805
*Since 22 November 2018

View citations on PubMed and Google Scholar